ABBOTT LABORATORIES Debt Repayment 2007-2026 | ABT
Beta
What is debt repayment?
Debt repayment represents cash used to pay down outstanding bonds, loans, and other debt obligations as they mature.
What is ABBOTT LABORATORIES's current debt repayment?
ABBOTT LABORATORIES (ABT) annual debt repayment for 2021 was $48.0M, a 96.40% decline from 2020. ABBOTT LABORATORIES debt repayment for the quarter ending March 31, 2026 was $1.42B.
What was ABBOTT LABORATORIES's debt repayment in 2020?
ABBOTT LABORATORIES annual debt repayment for 2020 was $1.33B, a 61.26% decline from 2019.
What was ABBOTT LABORATORIES's debt repayment in 2019?
ABBOTT LABORATORIES annual debt repayment for 2019 was $3.44B, a 72.32% decline from 2018.
What is ABBOTT LABORATORIES's 5-year debt repayment CAGR?
ABBOTT LABORATORIES debt repayment grew at a compound annual growth rate (CAGR) of 31.95% from FY2016 to FY2021, going from $12.0M to $48.0M over 5 years.
Debt Repayment History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR+32.0%
FY2016
$12.0M
→
FY2021
$48.0M
070809101112131415161718192021
5 years selected
Debt Repayment History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2021 | $48.0M | -96.4% | 10-K |
| FY2020 | $1.33B | -61.3% | 10-K |
| FY2019 | $3.44B | -72.3% | 10-K |
| FY2018 | $12.43B | +43.7% | 10-K |
| FY2017 | $8.65B | +71983.3% | 10-K |
| FY2016 | $12.0M | -78.9% | 10-K |
| FY2015 | $57.0M | -90.1% | 10-K |
| FY2014 | $577.0M | +90.4% | 10-K |
| FY2013 | $303.0M | -97.3% | 10-K |
| FY2012 | $11.07B | +267.6% | 10-K |
| FY2011 | $3.01B | +79.9% | 10-K |
| FY2010 | $1.67B | -32.6% | 10-K |
| FY2009 | $2.48B | +171.7% | 10-K |
| FY2008 | $913.9M | +107.2% | 10-K |
| FY2007 | $441.0M | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →